Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NHSL1 antisense RNA 1 (NHSL1-AS1, FLJ46906) is a long non-coding RNA upregulated in aging human skin fibroblasts. It directly binds the transcription factors NF-κB and AP-1, thereby influencing the expression of several aging-associated genes involved in inflammation (IL1B, IL6, CXCL8), extracellular matrix remodeling (TGFB1, ELN), and other cellular processes. It does not appear to regulate its neighboring genes in cis, nor act via a classic antisense RNA mechanism. Instead, its main effect is through modulation of transcription factor activity, implying a mechanistic role in cellular aging, especially in skin. No interactions with drugs, established biomarker roles, or clinical therapeutic indications are documented as of current research. If structured, this molecule can be confidently described as a long non-coding RNA involved in transcriptional regulation of aging-associated genes by binding to NF-κB and AP-1; it is not a classic therapeutic target or receptor, but is of biological interest in aging processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NHSL1 antisense RNA 1 (NHSL1-AS1).